Resultados da busca - Jay Azmi

Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics por Mark C. Liu, Bradley Chipps, Xavier Munoz, Gilles Devouassoux, Miguel Bergna, Steven G. Smith, Robert G. Price, Dmitry V. Galkin, Jay Azmi, Dalal Mouneimne, Frank C. Albers, Kenneth R. Chapman

Obter o texto integral